NeuroMetrix Launches DPNCheck 2.0 for Peripheral Neuropathy Screening

NeuroMetrix has launched its DPNCheck 2.0 point-of-care device to quantitatively measure peripheral neuropathy — damaged nerves at the extremities such as feet.

The device uses nerve conduction technology along with companion software to create clinical documentation of test results.

The device makes it “possible to uncover elevated risk for these complications earlier and more accurately than traditional clinical approaches such as the monofilament and tuning fork tests,” the company said.